CARTIA Drug Patent Profile
✉ Email this page to a colleague
When do Cartia patents expire, and when can generic versions of Cartia launch?
Cartia is a drug marketed by Actavis Labs Fl Inc and is included in one NDA.
The generic ingredient in CARTIA is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cartia
A generic version of CARTIA was approved as diltiazem hydrochloride by TEVA on May 31st, 1995.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CARTIA?
- What are the global sales for CARTIA?
- What is Average Wholesale Price for CARTIA?
Summary for CARTIA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Sales Revenues: | Drug sales revenues for CARTIA |
| DailyMed Link: | CARTIA at DailyMed |
US Patents and Regulatory Information for CARTIA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Fl Inc | CARTIA XT | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 074752-002 | Jul 9, 1998 | AB3 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Actavis Labs Fl Inc | CARTIA XT | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 074752-004 | Jul 9, 1998 | AB3 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Actavis Labs Fl Inc | CARTIA XT | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 074752-001 | Jul 9, 1998 | AB3 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Actavis Labs Fl Inc | CARTIA XT | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 074752-003 | Jul 9, 1998 | AB3 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
